Found 60 Enz. Inhib. hit(s) with all data for entry = 8532 TargetTransient receptor potential cation channel subfamily M member 8(Homo sapiens (Human))
Mitsubishi Tanabe Pharma
US Patent
Mitsubishi Tanabe Pharma
US Patent
Affinity DataIC50: 0.300nMT: 2°CAssay Description:The functional activity of a test compound was determined by measuring change in intracellular calcium concentration using a calcium sensitive fluore...More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily M member 8(Homo sapiens (Human))
Mitsubishi Tanabe Pharma
US Patent
Mitsubishi Tanabe Pharma
US Patent
Affinity DataIC50: 0.300nMT: 2°CAssay Description:The functional activity of a test compound was determined by measuring change in intracellular calcium concentration using a calcium sensitive fluore...More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily M member 8(Homo sapiens (Human))
Mitsubishi Tanabe Pharma
US Patent
Mitsubishi Tanabe Pharma
US Patent
Affinity DataIC50: 0.5nMT: 2°CAssay Description:The functional activity of a test compound was determined by measuring change in intracellular calcium concentration using a calcium sensitive fluore...More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily M member 8(Homo sapiens (Human))
Mitsubishi Tanabe Pharma
US Patent
Mitsubishi Tanabe Pharma
US Patent
Affinity DataIC50: 0.5nMT: 2°CAssay Description:The functional activity of a test compound was determined by measuring change in intracellular calcium concentration using a calcium sensitive fluore...More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily M member 8(Homo sapiens (Human))
Mitsubishi Tanabe Pharma
US Patent
Mitsubishi Tanabe Pharma
US Patent
Affinity DataIC50: 0.600nMT: 2°CAssay Description:The functional activity of a test compound was determined by measuring change in intracellular calcium concentration using a calcium sensitive fluore...More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily M member 8(Homo sapiens (Human))
Mitsubishi Tanabe Pharma
US Patent
Mitsubishi Tanabe Pharma
US Patent
Affinity DataIC50: 0.700nMT: 2°CAssay Description:The functional activity of a test compound was determined by measuring change in intracellular calcium concentration using a calcium sensitive fluore...More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily M member 8(Homo sapiens (Human))
Mitsubishi Tanabe Pharma
US Patent
Mitsubishi Tanabe Pharma
US Patent
Affinity DataIC50: 0.700nMT: 2°CAssay Description:The functional activity of a test compound was determined by measuring change in intracellular calcium concentration using a calcium sensitive fluore...More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily M member 8(Homo sapiens (Human))
Mitsubishi Tanabe Pharma
US Patent
Mitsubishi Tanabe Pharma
US Patent
Affinity DataIC50: 0.700nMT: 2°CAssay Description:The functional activity of a test compound was determined by measuring change in intracellular calcium concentration using a calcium sensitive fluore...More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily M member 8(Homo sapiens (Human))
Mitsubishi Tanabe Pharma
US Patent
Mitsubishi Tanabe Pharma
US Patent
Affinity DataIC50: 0.700nMT: 2°CAssay Description:The functional activity of a test compound was determined by measuring change in intracellular calcium concentration using a calcium sensitive fluore...More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily M member 8(Homo sapiens (Human))
Mitsubishi Tanabe Pharma
US Patent
Mitsubishi Tanabe Pharma
US Patent
Affinity DataIC50: 0.800nMT: 2°CAssay Description:The functional activity of a test compound was determined by measuring change in intracellular calcium concentration using a calcium sensitive fluore...More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily M member 8(Homo sapiens (Human))
Mitsubishi Tanabe Pharma
US Patent
Mitsubishi Tanabe Pharma
US Patent
Affinity DataIC50: 0.900nMT: 2°CAssay Description:The functional activity of a test compound was determined by measuring change in intracellular calcium concentration using a calcium sensitive fluore...More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily M member 8(Homo sapiens (Human))
Mitsubishi Tanabe Pharma
US Patent
Mitsubishi Tanabe Pharma
US Patent
Affinity DataIC50: 1nMT: 2°CAssay Description:The functional activity of a test compound was determined by measuring change in intracellular calcium concentration using a calcium sensitive fluore...More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily M member 8(Homo sapiens (Human))
Mitsubishi Tanabe Pharma
US Patent
Mitsubishi Tanabe Pharma
US Patent
Affinity DataIC50: 1nMT: 2°CAssay Description:The functional activity of a test compound was determined by measuring change in intracellular calcium concentration using a calcium sensitive fluore...More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily M member 8(Homo sapiens (Human))
Mitsubishi Tanabe Pharma
US Patent
Mitsubishi Tanabe Pharma
US Patent
Affinity DataIC50: 1nMT: 2°CAssay Description:The functional activity of a test compound was determined by measuring change in intracellular calcium concentration using a calcium sensitive fluore...More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily M member 8(Homo sapiens (Human))
Mitsubishi Tanabe Pharma
US Patent
Mitsubishi Tanabe Pharma
US Patent
Affinity DataIC50: 1.10nMT: 2°CAssay Description:The functional activity of a test compound was determined by measuring change in intracellular calcium concentration using a calcium sensitive fluore...More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily M member 8(Homo sapiens (Human))
Mitsubishi Tanabe Pharma
US Patent
Mitsubishi Tanabe Pharma
US Patent
Affinity DataIC50: 1.10nMT: 2°CAssay Description:The functional activity of a test compound was determined by measuring change in intracellular calcium concentration using a calcium sensitive fluore...More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily M member 8(Homo sapiens (Human))
Mitsubishi Tanabe Pharma
US Patent
Mitsubishi Tanabe Pharma
US Patent
Affinity DataIC50: 1.10nMT: 2°CAssay Description:The functional activity of a test compound was determined by measuring change in intracellular calcium concentration using a calcium sensitive fluore...More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily M member 8(Homo sapiens (Human))
Mitsubishi Tanabe Pharma
US Patent
Mitsubishi Tanabe Pharma
US Patent
Affinity DataIC50: 1.10nMT: 2°CAssay Description:The functional activity of a test compound was determined by measuring change in intracellular calcium concentration using a calcium sensitive fluore...More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily M member 8(Homo sapiens (Human))
Mitsubishi Tanabe Pharma
US Patent
Mitsubishi Tanabe Pharma
US Patent
Affinity DataIC50: 1.10nMT: 2°CAssay Description:The functional activity of a test compound was determined by measuring change in intracellular calcium concentration using a calcium sensitive fluore...More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily M member 8(Homo sapiens (Human))
Mitsubishi Tanabe Pharma
US Patent
Mitsubishi Tanabe Pharma
US Patent
Affinity DataIC50: 1.10nMT: 2°CAssay Description:The functional activity of a test compound was determined by measuring change in intracellular calcium concentration using a calcium sensitive fluore...More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily M member 8(Homo sapiens (Human))
Mitsubishi Tanabe Pharma
US Patent
Mitsubishi Tanabe Pharma
US Patent
Affinity DataIC50: 1.20nMT: 2°CAssay Description:The functional activity of a test compound was determined by measuring change in intracellular calcium concentration using a calcium sensitive fluore...More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily M member 8(Homo sapiens (Human))
Mitsubishi Tanabe Pharma
US Patent
Mitsubishi Tanabe Pharma
US Patent
Affinity DataIC50: 1.40nMT: 2°CAssay Description:The functional activity of a test compound was determined by measuring change in intracellular calcium concentration using a calcium sensitive fluore...More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily M member 8(Homo sapiens (Human))
Mitsubishi Tanabe Pharma
US Patent
Mitsubishi Tanabe Pharma
US Patent
Affinity DataIC50: 1.40nMT: 2°CAssay Description:The functional activity of a test compound was determined by measuring change in intracellular calcium concentration using a calcium sensitive fluore...More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily M member 8(Homo sapiens (Human))
Mitsubishi Tanabe Pharma
US Patent
Mitsubishi Tanabe Pharma
US Patent
Affinity DataIC50: 1.5nMT: 2°CAssay Description:The functional activity of a test compound was determined by measuring change in intracellular calcium concentration using a calcium sensitive fluore...More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily M member 8(Homo sapiens (Human))
Mitsubishi Tanabe Pharma
US Patent
Mitsubishi Tanabe Pharma
US Patent
Affinity DataIC50: 1.60nMT: 2°CAssay Description:The functional activity of a test compound was determined by measuring change in intracellular calcium concentration using a calcium sensitive fluore...More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily M member 8(Homo sapiens (Human))
Mitsubishi Tanabe Pharma
US Patent
Mitsubishi Tanabe Pharma
US Patent
Affinity DataIC50: 1.70nMT: 2°CAssay Description:The functional activity of a test compound was determined by measuring change in intracellular calcium concentration using a calcium sensitive fluore...More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily M member 8(Homo sapiens (Human))
Mitsubishi Tanabe Pharma
US Patent
Mitsubishi Tanabe Pharma
US Patent
Affinity DataIC50: 2nMT: 2°CAssay Description:The functional activity of a test compound was determined by measuring change in intracellular calcium concentration using a calcium sensitive fluore...More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily M member 8(Homo sapiens (Human))
Mitsubishi Tanabe Pharma
US Patent
Mitsubishi Tanabe Pharma
US Patent
Affinity DataIC50: 2.10nMT: 2°CAssay Description:The functional activity of a test compound was determined by measuring change in intracellular calcium concentration using a calcium sensitive fluore...More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily M member 8(Homo sapiens (Human))
Mitsubishi Tanabe Pharma
US Patent
Mitsubishi Tanabe Pharma
US Patent
Affinity DataIC50: 2.20nMT: 2°CAssay Description:The functional activity of a test compound was determined by measuring change in intracellular calcium concentration using a calcium sensitive fluore...More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily M member 8(Homo sapiens (Human))
Mitsubishi Tanabe Pharma
US Patent
Mitsubishi Tanabe Pharma
US Patent
Affinity DataIC50: 2.30nMT: 2°CAssay Description:The functional activity of a test compound was determined by measuring change in intracellular calcium concentration using a calcium sensitive fluore...More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily M member 8(Homo sapiens (Human))
Mitsubishi Tanabe Pharma
US Patent
Mitsubishi Tanabe Pharma
US Patent
Affinity DataIC50: 2.5nMT: 2°CAssay Description:The functional activity of a test compound was determined by measuring change in intracellular calcium concentration using a calcium sensitive fluore...More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily M member 8(Homo sapiens (Human))
Mitsubishi Tanabe Pharma
US Patent
Mitsubishi Tanabe Pharma
US Patent
Affinity DataIC50: 2.70nMT: 2°CAssay Description:The functional activity of a test compound was determined by measuring change in intracellular calcium concentration using a calcium sensitive fluore...More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily M member 8(Homo sapiens (Human))
Mitsubishi Tanabe Pharma
US Patent
Mitsubishi Tanabe Pharma
US Patent
Affinity DataIC50: 2.90nMT: 2°CAssay Description:The functional activity of a test compound was determined by measuring change in intracellular calcium concentration using a calcium sensitive fluore...More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily M member 8(Homo sapiens (Human))
Mitsubishi Tanabe Pharma
US Patent
Mitsubishi Tanabe Pharma
US Patent
Affinity DataIC50: 3nMT: 2°CAssay Description:The functional activity of a test compound was determined by measuring change in intracellular calcium concentration using a calcium sensitive fluore...More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily M member 8(Homo sapiens (Human))
Mitsubishi Tanabe Pharma
US Patent
Mitsubishi Tanabe Pharma
US Patent
Affinity DataIC50: 3.20nMT: 2°CAssay Description:The functional activity of a test compound was determined by measuring change in intracellular calcium concentration using a calcium sensitive fluore...More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily M member 8(Homo sapiens (Human))
Mitsubishi Tanabe Pharma
US Patent
Mitsubishi Tanabe Pharma
US Patent
Affinity DataIC50: 3.30nMT: 2°CAssay Description:The functional activity of a test compound was determined by measuring change in intracellular calcium concentration using a calcium sensitive fluore...More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily M member 8(Homo sapiens (Human))
Mitsubishi Tanabe Pharma
US Patent
Mitsubishi Tanabe Pharma
US Patent
Affinity DataIC50: 3.40nMT: 2°CAssay Description:The functional activity of a test compound was determined by measuring change in intracellular calcium concentration using a calcium sensitive fluore...More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily M member 8(Homo sapiens (Human))
Mitsubishi Tanabe Pharma
US Patent
Mitsubishi Tanabe Pharma
US Patent
Affinity DataIC50: 3.5nMT: 2°CAssay Description:The functional activity of a test compound was determined by measuring change in intracellular calcium concentration using a calcium sensitive fluore...More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily M member 8(Homo sapiens (Human))
Mitsubishi Tanabe Pharma
US Patent
Mitsubishi Tanabe Pharma
US Patent
Affinity DataIC50: 3.5nMT: 2°CAssay Description:The functional activity of a test compound was determined by measuring change in intracellular calcium concentration using a calcium sensitive fluore...More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily M member 8(Homo sapiens (Human))
Mitsubishi Tanabe Pharma
US Patent
Mitsubishi Tanabe Pharma
US Patent
Affinity DataIC50: 3.60nMT: 2°CAssay Description:The functional activity of a test compound was determined by measuring change in intracellular calcium concentration using a calcium sensitive fluore...More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily M member 8(Homo sapiens (Human))
Mitsubishi Tanabe Pharma
US Patent
Mitsubishi Tanabe Pharma
US Patent
Affinity DataIC50: 3.80nMT: 2°CAssay Description:The functional activity of a test compound was determined by measuring change in intracellular calcium concentration using a calcium sensitive fluore...More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily M member 8(Homo sapiens (Human))
Mitsubishi Tanabe Pharma
US Patent
Mitsubishi Tanabe Pharma
US Patent
Affinity DataIC50: 4.30nMT: 2°CAssay Description:The functional activity of a test compound was determined by measuring change in intracellular calcium concentration using a calcium sensitive fluore...More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily M member 8(Homo sapiens (Human))
Mitsubishi Tanabe Pharma
US Patent
Mitsubishi Tanabe Pharma
US Patent
Affinity DataIC50: 4.60nMT: 2°CAssay Description:The functional activity of a test compound was determined by measuring change in intracellular calcium concentration using a calcium sensitive fluore...More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily M member 8(Homo sapiens (Human))
Mitsubishi Tanabe Pharma
US Patent
Mitsubishi Tanabe Pharma
US Patent
Affinity DataIC50: 5.60nMT: 2°CAssay Description:The functional activity of a test compound was determined by measuring change in intracellular calcium concentration using a calcium sensitive fluore...More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily M member 8(Homo sapiens (Human))
Mitsubishi Tanabe Pharma
US Patent
Mitsubishi Tanabe Pharma
US Patent
Affinity DataIC50: 6.30nMT: 2°CAssay Description:The functional activity of a test compound was determined by measuring change in intracellular calcium concentration using a calcium sensitive fluore...More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily M member 8(Homo sapiens (Human))
Mitsubishi Tanabe Pharma
US Patent
Mitsubishi Tanabe Pharma
US Patent
Affinity DataIC50: 6.5nMT: 2°CAssay Description:The functional activity of a test compound was determined by measuring change in intracellular calcium concentration using a calcium sensitive fluore...More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily M member 8(Homo sapiens (Human))
Mitsubishi Tanabe Pharma
US Patent
Mitsubishi Tanabe Pharma
US Patent
Affinity DataIC50: 6.60nMT: 2°CAssay Description:The functional activity of a test compound was determined by measuring change in intracellular calcium concentration using a calcium sensitive fluore...More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily M member 8(Homo sapiens (Human))
Mitsubishi Tanabe Pharma
US Patent
Mitsubishi Tanabe Pharma
US Patent
Affinity DataIC50: 7.60nMT: 2°CAssay Description:The functional activity of a test compound was determined by measuring change in intracellular calcium concentration using a calcium sensitive fluore...More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily M member 8(Homo sapiens (Human))
Mitsubishi Tanabe Pharma
US Patent
Mitsubishi Tanabe Pharma
US Patent
Affinity DataIC50: 9.5nMT: 2°CAssay Description:The functional activity of a test compound was determined by measuring change in intracellular calcium concentration using a calcium sensitive fluore...More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily M member 8(Homo sapiens (Human))
Mitsubishi Tanabe Pharma
US Patent
Mitsubishi Tanabe Pharma
US Patent
Affinity DataIC50: 9.60nMT: 2°CAssay Description:The functional activity of a test compound was determined by measuring change in intracellular calcium concentration using a calcium sensitive fluore...More data for this Ligand-Target Pair
